However, both of the aforementioned molecules, CD38 and BCMA, are attractive targets to deplete long-lived plasma cells in antibody-driven neurological diseases such as NMOSD or antibody-mediated autoimmune encephalitides. Here, TNFRSF17 is linked to nervous system disorder.